CytRx Corporation has received a patent covering for its tumour-targeting linker platform technology and pharmaceutical compositions from the European Patent Office (EPO). The company also revealed aldoxorubucin as the new generic ...
Tags: Patent, pharmaceutical technology, pharmaceutical product
Biolase legal tussles continue 09 May 2012 The company has filed suit against a European competitor,and is also the subject of legal action from CAO Group. Two recently filed patent disputes involving Biolase indicate that the ...
Tags: Biolase, Legal Tussles, CAO Group, 09 May 2012
Rosetta Genomics has won a European patent covering the use of miR-34a in the preparation of pharmaceuticals used to treat p53-negative cancers. The patent covers a core element of Rosetta's microRNA technology in the development of ...
Tags: European patent, p53-negative cancer, miR-34a, clinical technology
Patents held by UK-based Integration Technology Ltd (ITL) and North American based Lumen Dynamics Group Inc. (LDGI) are to be cross-licensed, enabling ITL products entry to the North American market and Lumen Dynamics enhanced access to its ...
Tags: uv led light